Physician profile
Nancy Devries
NPI 1902358310
$13,355.72
in general payments reported to CMS, 2019-2025
69 companies · $4,983 in 2025
The $4,983 reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,396 · 2023: $3,416 · 2024: $3,560 · 2025: $4,983.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $753.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $11,206.73 |
| Education | $753.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $975.27 | 2022-2025 | Enhertu, Imfinzi, Tagrisso |
| Novartis Pharmaceuticals Corporation | $939.08 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $908.57 | 2022-2025 | Keytruda, Lynparza, Welireg |
| Incyte Corporation | $792.74 | 2022-2025 | Jakafi, Monjuvi, Niktimvo |
| Janssen Biotech, INC. | $712.04 | 2022-2025 | Tecvayli, Darzalex, Erleada |
| Daiichi Sankyo INC. | $663.61 | 2022-2025 | Enhertu, Injectafer, Datroway |
| Celgene Corporation | $656.13 | 2022-2025 | Reblozyl, Pomalyst, Opdualag |
| Pfizer INC. | $576.22 | 2023-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $547.10 | 2023-2025 | Ninlaro, Fruzaqla, Vpriv |
| Seagen INC. | $457.22 | 2022-2025 | Padcev, Adcetris, Tivdak |
| E.R. Squibb & Sons, L.L.C. | $451.04 | 2022-2025 | Opdivo, Opdualag |
| Gilead Sciences, INC. | $450.33 | 2022-2025 | Trodelvy |
| Abbvie INC. | $323.24 | 2022-2025 | |
| Kite Pharma, INC. | $307.76 | 2022-2025 | Yescarta |
| Beigene USA, INC. | $294.12 | 2022-2025 | Brukinsa |
Show all 69 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $289.13 | 2023-2025 | Ojjaara, Jemperli, Zejula |
| Lilly USA, LLC | $234.57 | 2022-2025 | Jaypirca, Verzenio, Retevmo |
| Eisai INC. | $232.67 | 2022-2025 | |
| Array Biopharma INC | $202.85 | 2023-2025 | Braftovi, Mektovi, Lorbrena |
| Ipsen Biopharmaceuticals, INC | $195.83 | 2025 | Onivyde |
| Regeneron Healthcare Solutions, INC. | $189.34 | 2024-2025 | Libtayo, Lynozyfic |
| Karyopharm Therapeutics INC. | $186.32 | 2022-2024 | Xpovio |
| Jazz Pharmaceuticals INC. | $181.57 | 2024-2025 | |
| Emd Serono, INC. | $136.92 | 2022-2025 | Bavencio |
| Intuitive Surgical, INC. | $134.62 | 2025 | |
| Astellas Pharma US INC | $128.55 | 2023-2025 | Padcev |
| Taiho Oncology, INC. | $117.45 | 2024-2025 | |
| Pulmonx Corporation | $110.45 | 2025 | Chartis Catheter, Zephyr Endobronchial Valve, Zephyr Delivery Catheter |
| Pharmaessentia USA Corporation | $109.41 | 2023-2025 | Besremi |
| Tersera Therapeutics LLC | $108.71 | 2023-2025 | Quzyttir, Zoladex, Xermelo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $108.53 | 2022-2025 | Gilotrif |
| Pharmacyclics LLC, An Abbvie Company | $104.04 | 2023 | Imbruvica |
| Beone Medicines USA, INC. | $93.97 | 2025 | Brukinsa |
| Genzyme Corporation | $92.28 | 2022-2025 | |
| Genentech USA, INC. | $91.87 | 2022-2024 | Tecentriq, Lunsumio, Polivy |
| Alexion Pharmaceuticals, INC. | $89.59 | 2023-2024 | Ultomiris |
| Geron Corporation | $88.04 | 2025 | Rytelo |
| Stemline Therapeutics INC. | $76.61 | 2023-2025 | Orserdu |
| Amgen INC. | $75.70 | 2022-2023 | Lumakras |
| Sumitomo Pharma America, INC. | $71.73 | 2023-2025 | Orgovyx |
| Sobi, INC | $70.99 | 2022-2025 | |
| Pharmacosmos Therapeutics INC. | $69.31 | 2023-2025 | Monoferric |
| Myriad Genetic Laboratories, INC. | $58.58 | 2022-2025 | Myrisk |
| Recordati_rare_diseases_inc. | $58.00 | 2022-2025 | Enjaymo |
| Aveo Pharmaceuticals, INC. | $50.71 | 2022-2025 | |
| Puma Biotechnology, INC. | $49.38 | 2023-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $42.00 | 2022 | |
| Genmab U.S., INC. | $38.46 | 2024-2025 | Epkinly |
| Legend Biotech USA INC. | $36.86 | 2025 | Carvykti |
| Blueprint Medicines Corporation | $36.45 | 2025 | Ayvakit |
| Deciphera Pharmaceuticals INC. | $31.30 | 2023-2025 | Qinlock, Romvimza |
| Immunocore Limited | $30.27 | 2025 | Kimmtrak |
| G1 Therapeutics, INC. | $30.14 | 2022-2023 | Cosela |
| Dendreon Pharmaceuticals LLC | $24.24 | 2023 | Provenge |
| Kyowa Kirin, INC. | $23.41 | 2023 | Poteligeo |
| Viiv Healthcare Company | $22.90 | 2025 | |
| Foundation Medicine, INC. | $16.34 | 2023 | |
| Novocure INC. | $16.01 | 2025 | Optune Lua (Novottf-200t) |
| Fennec Pharmaceuticals, INC. | $15.64 | 2025 | Fyarro |
| Myovant Sciences INC. | $15.31 | 2022 | |
| Iovance Biotherapeutics, INC. | $14.98 | 2025 | Amtagvi |
| Mirati Therapeutics, INC. | $13.81 | 2023 | Krazati |
| Amag Pharmaceuticals, INC. | $13.67 | 2022 | |
| Adc Therapeutics America, INC. | $13.49 | 2024 | |
| Apellis Pharmaceuticals, INC. | $13.47 | 2023 | Empaveli |
| Agios Pharmaceuticals, INC. | $13.18 | 2023 | Pyrukynd |
| Eusa Pharma (US) LLC | $13.08 | 2022 | |
| Alnylam Pharmaceuticals INC. | $11.67 | 2022 | |
| Pharmaand Gmbh | $6.85 | 2025 | Rubraca |
Drugs and devices associated with these payments
Enhertu $933Keytruda $875Lynparza $433Reblozyl $429Imbruvica $360Brukinsa $351Jakafi $347Padcev $303Adcetris $274Tecvayli $260Imfinzi $255Pluvicto $245Elrexfio $237Kisqali $234Trodelvy $220Epkinly $216Monjuvi $215Opdivo $209Ojjaara $208Tukysa $203Lenvima $199Darzalex $188Braftovi $186Jaypirca $174Ibrance $165Ninlaro $162Zepzelca $159Fruzaqla $152Erleada $147Mektovi $147Yescarta $145Lorbrena $136Fabhalta $136Da Vinci Surgical System $135Libtayo $133Tagrisso $125Lonsurf $117Bosulif $117Scemblix $117Pulmonx Chartis Tablet Console $110Zephyr Delivery Catheter $110Chartis Catheter $110Zephyr Endobronchial Valve $110Besremi $109Talvey $100Inqovi $98.73Onivyde $96.84Calquence $92.25Opdualag $90.77Pomalyst $90.71Ultomiris $89.59Rytelo $88.04Xtandi $79.98Venclexta $77.90Verzenio $77.18Orserdu $76.61Rybrevant $75.85Orgovyx $71.73Vpriv $70.16Monoferric $69.31Piqray $64.92Xalkori $63.74Lynozyfic $56.83Hyqvia $56.12Tabrecta $56.02Quzyttir $55.76Xpovio $54.26Ayvakit $53.26Tivdak $50.73Alunbrig $49.26Enjaymo $47.55Tasigna $47.28Carvykti $42.56Welireg $42.08Myrisk $41.77Inlyta $40.95Vonjo $39.67Zoladex $39.29Comirnaty $38.81Nerlynx $35.38Vonvendi $35.19Jemperli $34.33Zejula $34.33Fotivda $34.25Bavencio $34.06Tecentriq $31.56Qinlock $31.30Kimmtrak $30.27Gilotrif $28.09Keytruda Qlex $27.84Injectafer $27.74Retevmo $27.15Shingrix $27.12Provenge $24.24Datroway $24.09Niktimvo $23.90Poteligeo $23.41Ziihera $22.51Blenrep $19.53Promacta $19.32
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nancy Devries listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.